Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Individualized prediction of colon cancer recurrence using a nomogram.

Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD.

J Clin Oncol. 2008 Jan 20;26(3):380-5. doi: 10.1200/JCO.2007.14.1291.

PMID:
18202413
2.

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP.

J Urol. 2006 Oct;176(4 Pt 1):1354-61; discussion 1361-2.

PMID:
16952631
3.

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, Lerner SP.

Clin Cancer Res. 2006 Nov 15;12(22):6663-76.

4.
5.

Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence.

Burdy G, Panis Y, Alves A, Nemeth J, Lavergne-Slove A, Valleur P.

Dis Colon Rectum. 2001 Nov;44(11):1682-8.

PMID:
11711742
6.

Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.

Chi DS, Palayekar MJ, Sonoda Y, Abu-Rustum NR, Awtrey CS, Huh J, Eisenhauer EL, Barakat RR, Kattan MW.

Gynecol Oncol. 2008 Jan;108(1):191-4. Epub 2007 Oct 24.

PMID:
17950784
7.

Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.

Hupertan V, Roupret M, Poisson JF, Chretien Y, Dufour B, Thiounn N, Mejean A.

Cancer. 2006 Dec 1;107(11):2604-8.

8.

Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.

Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM.

J Clin Oncol. 2008 May 1;26(13):2112-7. doi: 10.1200/JCO.2007.14.7934. Epub 2008 Mar 31.

PMID:
18378567
9.

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Dis Colon Rectum. 2008 May;51(5):503-7. doi: 10.1007/s10350-008-9246-z. Epub 2008 Mar 6.

PMID:
18322753
10.

A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.

Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D'Angelica MI, Blumgart LH, DeMatteo RP.

J Am Coll Surg. 2008 Feb;206(2):281-91. doi: 10.1016/j.jamcollsurg.2007.07.031. Epub 2007 Oct 29.

PMID:
18222381
11.

Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer.

Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H.

Dis Colon Rectum. 2003 Aug;46(8):1054-9.

PMID:
12907899
12.

A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.

Kattan MW, Gönen M, Jarnagin WR, DeMatteo R, D'Angelica M, Weiser M, Blumgart LH, Fong Y.

Ann Surg. 2008 Feb;247(2):282-7. doi: 10.1097/SLA.0b013e31815ed67b.

PMID:
18216534
13.

Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.

Lagarde SM, Reitsma JB, Ten Kate FJ, Busch OR, Obertop H, Zwinderman AH, Moons J, van Lanschot JJ, Lerut T.

Ann Surg. 2008 Dec;248(6):1006-13. doi: 10.1097/SLA.0b013e318190a0a2.

PMID:
19092345
14.

Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.

Rouprêt M, Hupertan V, Comperat E, Drouin SJ, Phé V, Xylinas E, Demanse D, Sibony M, Richard F, Cussenot O.

BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27.

15.

Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML.

Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1.

PMID:
18838212
16.

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.

Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI.

J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669.

PMID:
18349404
17.

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.

Kattan MW, Karpeh MS, Mazumdar M, Brennan MF.

J Clin Oncol. 2003 Oct 1;21(19):3647-50.

PMID:
14512396
18.

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.

Catto JW, Abbod MF, Linkens DA, Larré S, Rosario DJ, Hamdy FC.

Clin Cancer Res. 2009 May 1;15(9):3150-5. doi: 10.1158/1078-0432.CCR-08-1960. Epub 2009 Mar 31.

19.

Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.

Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.

J Urol. 2009 Feb;181(2):480-5; discussion 485. doi: 10.1016/j.juro.2008.10.017. Epub 2008 Dec 19.

PMID:
19100568
20.

Development and validation of a nomogram for predicting outcome of patients with vulvar cancer.

Rouzier R, Preti M, Haddad B, Martin M, Micheletti L, Paniel BJ.

Obstet Gynecol. 2006 Mar;107(3):672-7.

PMID:
16507940

Supplemental Content

Support Center